Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year period.
Braun J, Deodhar A, Dijkmans B, Geusens P, Sieper J, Williamson P, Xu W, Visvanathan S, Baker D, Goldstein N, van der Heijde D; Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group.
Braun J, et al. Among authors: xu w.
Arthritis Rheum. 2008 Sep 15;59(9):1270-8. doi: 10.1002/art.24001.
Arthritis Rheum. 2008.
PMID: 18759257
Free article.
Clinical Trial.